Abstract
The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine–rich RING motif, a zinc–binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N–terminal region of BRCA1. This BRCA1–associated RING domain (BARD1) protein contains an N–terminal RING motif, three tandem ankyrin repeats, and a C–terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
Castilla, L.H. et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 8, 387–391 (1994).
Simard, J. et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet. 8, 392–398 (1994).
Friedman, L.S. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8, 399–404 (1994).
Easton, D.F., Bishop, D.T., Ford, D. & Crockford, G.P. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 52, 678–701 (1993).
Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A. & Goldgar, D.E. Risks of cancer in BRCA1 -mutation carriers. Breast Cancer Linkage Consortium. Lancet 343, 692–695 (1994).
Saurin, A.J., Borden, K.L.B., Boddy, M.N. & Freemont, P.S. Does this have a familiar RING? Trends Biochem. Sci. 21, 208–214 (1996).
Bennett, M.L. et al. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics 29, 576–581 (1995).
Lane, T.F. et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712–2722 (1995).
Sharan, S.K., Wims, M. & Bradley, A. Murine Brca1: sequence and significance for human missense mutations. Hum. Mot. Genet. 4, 2275–2278 (1995).
Koonin, E.V., Altschul, S.F. & Bork, P. BRCA1 protein products: functional motifs. Nature Genet. 13, 266–267 (1996).
Fields, S. & Song, O. -k. A novel genetic system to detect protein–protein interactions. Nature 340, 245–246 (1989).
Chien, C.-t., Bartel, P.L., Sternglanz, R. & Fields, S. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88, 9578–9582 (1991).
Durfee, T. et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7, 555–569 (1993).
Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).
Dang, C.V. et al. Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization. Mol. Cell. Biol. 11, 954–962 (1991).
Hsu, H.-L., Wadman, I. & Baer, R. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc. Natl. Acad. Sci. USA 91, 3181–3185 (1994).
Tsan, J.T. et al. Mammalian cells as hosts for two-hybrid studies of protein–protein interaction. in The Yeast Two-hybrid System (eds. Bartel, P.L & Fields, S.) (Oxford University Press, Oxford, in the press).
Hopp, T.P. et al. A short polypeptide marker sequence useful for recombinant protein identification and purification. BioTechnology 6, 1204–1210 (1988).
Bork, P. Hundreds of ankyrin-like repeats in functionally diverse proteins: Mobile modules that cross phyla horizontally. Prot. Struct. Funct. Genet. 17, 363–374 (1993).
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
Landschulz, W.H., Johnson, P.F. & McKnight, S.L. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759–1764 (1988).
Murre, C., McCaw, P.S. & Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777–783 (1989).
Sadowski, I., Bell, B., Broad, P. & Hollis, M. GAL4 fusion vectors for expression in yeast or mammalian cells. Gene 118, 137–141 (1992).
Andersson, S., Davis, D.N., Dahlback, H., Jornvall, H. & Russell, D.W., Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264, 8222–8229 (1989).
Smith, D.B. & Johnson, K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31–40 (1988).
Guan, K. & Dixon, J.E. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Analyt. Biochem. 192, 262–267 (1991).
Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular cloning: a laboratory manual (Cold Spring Harbor Press, Cold Spring Harbor, New York, 1989).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, L., Wang, Z., Tsan, J. et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14, 430–440 (1996). https://doi.org/10.1038/ng1296-430
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1296-430
This article is cited by
-
Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?
Hereditary Cancer in Clinical Practice (2023)
-
BARD1 mystery: tumor suppressors are cancer susceptibility genes
BMC Cancer (2022)
-
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
npj Precision Oncology (2022)
-
Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants
Scientific Reports (2022)
-
RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant
Scientific Reports (2021)